Eli Lilly and Company (LLY): A Bull Case Theory 

We came across a bullish thesis on Eli Lilly and Company on Kontra Investments’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company’s share was trading at $724.54 as of September 26th. LLY’s trailing and forward P/E were 47.36 and 24.04 respectively according to Yahoo Finance.

5 Countries with the Highest Rates of Diabetes

Photo by Matt C on Unsplash

Few companies have captured investor attention like Eli Lilly, which has emerged as the leader in the obesity treatment...